“massachusetts-general-hospital” Archives

Entry Author Date Location
Alkermes Eyes FDA Nod After Retooled Study Yields Desired Results 10/20/16 Boston
Here’s the Agenda for What’s Hot in Boston Healthtech on Nov. 17 10/19/16 Boston
Business Leaders Convene for What’s Hot in Boston Healthtech on Nov. 17 09/09/16 Boston
Ex-Epizyme CEO’s New Startup, Fulcrum, Nabs $55M For Gene Control Drugs 07/19/16 Boston
How Cyber Visibility Protects Against the Abnormal & the Immoral 07/13/16 Boston
Roundup: RetroSense, America’s Greatest Makers, Naturalicious & More 06/28/16 Detroit Ann Arbor
Strata Oncology Closes $12M Round, Aims to Increase Tumor Sequencing 06/06/16 Detroit Ann Arbor
StartingBlock, Cellectar & 500 Startups: This Week’s WI Watchlist 05/20/16 Wisconsin
MGH Goes Epic: What I Learned in the Trenches 05/10/16 Boston
From Alexa to Watson, Boston Children’s Hospital Ups Digital Focus 03/30/16 Boston
Boston Tech Watch: Telehealth, Fantasy Sports, Cleantech, More 02/29/16 Boston
Atlas5D Snags $3M For Sensor Devices That Balance Data & Privacy 02/01/16 Boston
Depression Trials Fail, Alkermes Sees Silver Lining. Investors Don’t. 01/21/16 Boston
Amid Neuroscience Renaissance, BlackThorn Quietly Builds a Business 12/23/15 San Francisco
NinePoint, Under New Leadership, Bags $31M More For Imaging Tech 11/30/15 Boston
Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M 11/17/15 Boston
Taris 2.0: A Year After Buyout, VCs Bet $32M More on a Second Strike 10/27/15 Boston
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology 10/20/15 San Francisco
With PCSK9’s Origins In Mind, Sanofi Has UT Join Funding Program 07/09/15 Texas
XTuit Gets $22M From NEA, Polaris to Battle Cancer, Liver Disease 06/11/15 Boston
ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer 04/21/15 Boston
Biotech M&A by Slow Simmer: An Inside Look at the Build to Buy Deal 02/18/15 New York
Ready, Aim, CRISPR: Will Gene-Editing Tools Hit Their Targets? 02/17/15 National
Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M 01/28/15 Boston
Intrigue and Outdated Rules Complicate Big Biotech Patent Fight 12/16/14 National
Famed Geneticist Altshuler Bolts Broad Institute for Vertex 12/15/14 Boston
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
After Unlikely Idenix Sale, Renaud Jumps to RaNA to Outfox Junk DNA 12/01/14 Boston
MassChallenge Winner From MIT Aims to Kill Cancer With a “Squeeze” 11/24/14 Boston
RetroSense Closer to Clinical Trials After Orphan Drug Designation 11/05/14 Detroit Ann Arbor
Page 1 of 5 next page »